Cargando…

The Sphingolipid Inhibitors Ceranib-2 and SKI-II Reduce Measles Virus Replication in Primary Human Lymphocytes: Effects on mTORC1 Downstream Signaling

The bioactive sphingolipids ceramide and sphingosine-1-phosphate (S1P) are involved in the regulation of cell homeostasis and activity ranging from apoptosis to proliferation. We recently described that the two compounds ceranib-2 (inhibiting acid ceramidase) and SKI-II [inhibiting the sphingosine k...

Descripción completa

Detalles Bibliográficos
Autores principales: Chithelen, Janice, Franke, Hannah, Länder, Nora, Grafen, Anika, Schneider-Schaulies, Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968423/
https://www.ncbi.nlm.nih.gov/pubmed/35370781
http://dx.doi.org/10.3389/fphys.2022.856143
_version_ 1784679041968635904
author Chithelen, Janice
Franke, Hannah
Länder, Nora
Grafen, Anika
Schneider-Schaulies, Jürgen
author_facet Chithelen, Janice
Franke, Hannah
Länder, Nora
Grafen, Anika
Schneider-Schaulies, Jürgen
author_sort Chithelen, Janice
collection PubMed
description The bioactive sphingolipids ceramide and sphingosine-1-phosphate (S1P) are involved in the regulation of cell homeostasis and activity ranging from apoptosis to proliferation. We recently described that the two compounds ceranib-2 (inhibiting acid ceramidase) and SKI-II [inhibiting the sphingosine kinases 1 and − 2 (SphK1/2)] reduce mTORC1 activity and measles virus (MV) replication in human primary peripheral blood lymphocytes (PBL) by about one log step. We now further investigated whether mTORC1 downstream signaling and viral protein expression may be affected by ceranib-2 and/or SKI-II. Western blot analyses showed that in uninfected cells the phosphorylation of the eukaryotic initiation factor 4E (eIF4E) was reduced by both inhibitors. Interestingly, MV infection led to an increase of rpS6 protein levels and phosphorylation of eIF4E. Treatment with both inhibitors reduced the rpS6 protein expression, and in addition, SKI-II reduced rpS6 phosphorylation. The phosphorylation of eIF4E was slightly reduced by both inhibitors. In addition, SKI-II led to reduced levels of IKK in MV-infected cells. Both inhibitors reduced the expression of viral proteins and the titers of newly synthesized MV by approximately one log step. As expected, SKI-II and rapamycin reduced also the virally encoded GFP expression; however, ceranib-2 astonishingly led to increased levels of GFP fluorescence. Our findings suggest that the inhibitors ceranib-2 and SKI-II act via differential mechanisms on MV replication. The observed effects on mTORC1 downstream signaling, predominantly the reduction of rpS6 levels by both inhibitors, may affect the translational capacity of the cells and contribute to the antiviral effect in human primary PBL.
format Online
Article
Text
id pubmed-8968423
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89684232022-04-01 The Sphingolipid Inhibitors Ceranib-2 and SKI-II Reduce Measles Virus Replication in Primary Human Lymphocytes: Effects on mTORC1 Downstream Signaling Chithelen, Janice Franke, Hannah Länder, Nora Grafen, Anika Schneider-Schaulies, Jürgen Front Physiol Physiology The bioactive sphingolipids ceramide and sphingosine-1-phosphate (S1P) are involved in the regulation of cell homeostasis and activity ranging from apoptosis to proliferation. We recently described that the two compounds ceranib-2 (inhibiting acid ceramidase) and SKI-II [inhibiting the sphingosine kinases 1 and − 2 (SphK1/2)] reduce mTORC1 activity and measles virus (MV) replication in human primary peripheral blood lymphocytes (PBL) by about one log step. We now further investigated whether mTORC1 downstream signaling and viral protein expression may be affected by ceranib-2 and/or SKI-II. Western blot analyses showed that in uninfected cells the phosphorylation of the eukaryotic initiation factor 4E (eIF4E) was reduced by both inhibitors. Interestingly, MV infection led to an increase of rpS6 protein levels and phosphorylation of eIF4E. Treatment with both inhibitors reduced the rpS6 protein expression, and in addition, SKI-II reduced rpS6 phosphorylation. The phosphorylation of eIF4E was slightly reduced by both inhibitors. In addition, SKI-II led to reduced levels of IKK in MV-infected cells. Both inhibitors reduced the expression of viral proteins and the titers of newly synthesized MV by approximately one log step. As expected, SKI-II and rapamycin reduced also the virally encoded GFP expression; however, ceranib-2 astonishingly led to increased levels of GFP fluorescence. Our findings suggest that the inhibitors ceranib-2 and SKI-II act via differential mechanisms on MV replication. The observed effects on mTORC1 downstream signaling, predominantly the reduction of rpS6 levels by both inhibitors, may affect the translational capacity of the cells and contribute to the antiviral effect in human primary PBL. Frontiers Media S.A. 2022-03-17 /pmc/articles/PMC8968423/ /pubmed/35370781 http://dx.doi.org/10.3389/fphys.2022.856143 Text en Copyright © 2022 Chithelen, Franke, Länder, Grafen and Schneider-Schaulies. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Chithelen, Janice
Franke, Hannah
Länder, Nora
Grafen, Anika
Schneider-Schaulies, Jürgen
The Sphingolipid Inhibitors Ceranib-2 and SKI-II Reduce Measles Virus Replication in Primary Human Lymphocytes: Effects on mTORC1 Downstream Signaling
title The Sphingolipid Inhibitors Ceranib-2 and SKI-II Reduce Measles Virus Replication in Primary Human Lymphocytes: Effects on mTORC1 Downstream Signaling
title_full The Sphingolipid Inhibitors Ceranib-2 and SKI-II Reduce Measles Virus Replication in Primary Human Lymphocytes: Effects on mTORC1 Downstream Signaling
title_fullStr The Sphingolipid Inhibitors Ceranib-2 and SKI-II Reduce Measles Virus Replication in Primary Human Lymphocytes: Effects on mTORC1 Downstream Signaling
title_full_unstemmed The Sphingolipid Inhibitors Ceranib-2 and SKI-II Reduce Measles Virus Replication in Primary Human Lymphocytes: Effects on mTORC1 Downstream Signaling
title_short The Sphingolipid Inhibitors Ceranib-2 and SKI-II Reduce Measles Virus Replication in Primary Human Lymphocytes: Effects on mTORC1 Downstream Signaling
title_sort sphingolipid inhibitors ceranib-2 and ski-ii reduce measles virus replication in primary human lymphocytes: effects on mtorc1 downstream signaling
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968423/
https://www.ncbi.nlm.nih.gov/pubmed/35370781
http://dx.doi.org/10.3389/fphys.2022.856143
work_keys_str_mv AT chithelenjanice thesphingolipidinhibitorsceranib2andskiiireducemeaslesvirusreplicationinprimaryhumanlymphocyteseffectsonmtorc1downstreamsignaling
AT frankehannah thesphingolipidinhibitorsceranib2andskiiireducemeaslesvirusreplicationinprimaryhumanlymphocyteseffectsonmtorc1downstreamsignaling
AT landernora thesphingolipidinhibitorsceranib2andskiiireducemeaslesvirusreplicationinprimaryhumanlymphocyteseffectsonmtorc1downstreamsignaling
AT grafenanika thesphingolipidinhibitorsceranib2andskiiireducemeaslesvirusreplicationinprimaryhumanlymphocyteseffectsonmtorc1downstreamsignaling
AT schneiderschauliesjurgen thesphingolipidinhibitorsceranib2andskiiireducemeaslesvirusreplicationinprimaryhumanlymphocyteseffectsonmtorc1downstreamsignaling
AT chithelenjanice sphingolipidinhibitorsceranib2andskiiireducemeaslesvirusreplicationinprimaryhumanlymphocyteseffectsonmtorc1downstreamsignaling
AT frankehannah sphingolipidinhibitorsceranib2andskiiireducemeaslesvirusreplicationinprimaryhumanlymphocyteseffectsonmtorc1downstreamsignaling
AT landernora sphingolipidinhibitorsceranib2andskiiireducemeaslesvirusreplicationinprimaryhumanlymphocyteseffectsonmtorc1downstreamsignaling
AT grafenanika sphingolipidinhibitorsceranib2andskiiireducemeaslesvirusreplicationinprimaryhumanlymphocyteseffectsonmtorc1downstreamsignaling
AT schneiderschauliesjurgen sphingolipidinhibitorsceranib2andskiiireducemeaslesvirusreplicationinprimaryhumanlymphocyteseffectsonmtorc1downstreamsignaling